Detect reduced left ventricular ejection fraction using a three-lead ECG and heart sounds with AI
Official title: Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence
Run by Eko Devices, Inc. · NCT07270692 · Data updated 2026-11-12
This will test whether an AI that uses a three-lead ECG and digital stethoscope heart sounds can tell if an adult has an ejection fraction ≤ 40%.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Eko Devices, Inc. Industry-sponsored |
| Locations | 1 site (Mumbai, Maharashtra) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | October 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT07270692 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older who can give informed consent and complete a clinical echocardiogram within seven days before or after the recordings are ideal candidates.
✕Probably not a fit
Hospitalized patients and those unable to provide informed consent or complete a timely echocardiogram are not eligible and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study trains and evaluates an algorithm to predict an ejection fraction ≤ 40% using inputs from a three-lead ECG and heart sounds captured by Eko digital stethoscopes. Clinical echocardiogram results within seven days of recording serve as the reference standard for left ventricular ejection fraction. The project also examines how algorithm performance varies by age, gender, and race. Participants are adult outpatients able to give consent and undergo the required echocardiogram.
Why it matters
Potential benefit: If successful, the approach could provide a low-cost, noninvasive way to screen adults for reduced ejection fraction earlier and more broadly.
How similar studies have gone: Prior work using AI on standard 12-lead ECGs has shown promise for detecting low ejection fraction, but combining three-lead ECGs with digital stethoscope heart sounds is less tested and more novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years and older * Able and willing to provide informed consent * Complete a clinical echocardiogram within 7 days before or after study procedures Exclusion Criteria: * Unwilling or unable to provide informed consent * Patients who are hospitalized
Where it's running
-
P. D. Hinduja Hospital and Medical Research Centre
Mumbai, Maharashtra, India Recruiting
Study contacts
- Study coordinator: Clinical Research Associate
- Email: jackrin.walsh@ekohealth.com
- Phone: 8443563384
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collecting lung sound recordings using Eko digital stethoscopes in clinic
This project will try to teach computer programs to recognize wheeze, crackles, rhonchi, stridor, rales, and cough from stethoscope recordings in adults with suspected or diagnosed lung conditions and in people with normal lungs.
-
Recording lung sounds with Eko digital stethoscopes in clinic
This project will test an AI that listens to lung sounds recorded with Eko digital stethoscopes to find abnormal sounds in people with or without lung disease.
-
Screening for pulmonary hypertension with the Eko CORE 500 digital stethoscope
This project will test whether synchronized heart-sound and three-lead ECG recordings from the Eko CORE 500 can help detect pulmonary hypertension in adults undergoing a clinical echocardiogram or right-heart catheterization.
-
Digital stethoscope and 3-lead ECG detection of pulmonary hypertension and low ejection fraction
This project will test whether heart sounds and a three-lead ECG recorded with a digital stethoscope can find pulmonary hypertension or low left ventricular ejection fraction in adults having an echocardiogram.
-
Detecting pulmonary hypertension using an electronic stethoscope
This study is testing if a special electronic stethoscope can help doctors spot signs of pulmonary hypertension earlier in adults who are already being checked for this condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.